Alerts will be sent to your verified email
Verify Email
PPLPHARMA
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Piramal Pharma Limited provides a range of products and services through global manufacturing capabilities and distribution networks. Its offerings include integrated Contract Development and Manufacturing, Complex Hospital Generics, and Consumer Healthcare products across multiple countries.
Piramal Pharma major competitors are Cohance Lifesciences, Suven Life Sciences, Hikal, Syngene Internation., Sun Pharma Adv. Res, Dishman Carbogen Amc, Zenotech Laboratorie.
Market Cap of Piramal Pharma is ₹23,920 Crs.
While the median market cap of its peers are ₹3,870 Crs.
Piramal Pharma seems to be less financially stable compared to its competitors.
Altman Z score of Piramal Pharma is 3.47 and is ranked 5 out of its 8 competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | May Jul Nov | Mar Jun Sep Dec | Mar Jun Sep Dec | Sep Dec | ||||||||||||||
| Investor Presentation | May Jul Nov | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Sep Dec | ||||||||||||||
| Conference Call | Mar Nov | Mar Jun Sep Dec | Mar Jun Sep Dec | Sep Dec | ||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
